Unseen Enemy: Mechanisms of Multidrug Antimicrobial Resistance in Gram-Negative ESKAPE Pathogens

Giedrė Valdonė Sakalauskienė1, Lina Malcienė1, Edgaras Stankevičius1

  • 1Institute of Physiology and Pharmacology, Faculty of Medicine, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.

PubMed

Insights

Multidrug antimicrobial resistance (AMR) in gram-negative ESKAPE pathogens is a major global health threat. Understanding resistance mechanisms like drug efflux and target modification is crucial for developing new treatments.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Multidrug antimicrobial resistance (AMR) poses a significant challenge in treating infections, especially from gram-negative ESKAPE pathogens.
  • ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp.) are a priority due to rising resistance.
  • The COVID-19 pandemic exacerbated the threat, with coinfections leading to poorer patient outcomes and increased mortality.

Purpose of the Study:

  • To review the sophisticated mechanisms driving AMR in gram-negative ESKAPE bacteria.
  • To focus on Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Enterobacter spp.
  • To highlight the importance of understanding these mechanisms for developing new therapies.

Main Methods:

  • Literature review of scientific articles and reports on antimicrobial resistance in ESKAPE pathogens.
  • Analysis of key bacterial resistance mechanisms.
  • Synthesis of information on drug uptake, enzyme degradation, target modification, and efflux systems.

Main Results:

  • Gram-negative ESKAPE bacteria employ diverse strategies to resist antibiotics.
  • Mechanisms include reduced drug permeability, antibiotic-inactivating enzymes, altered drug targets, and active efflux pumps.
  • These mechanisms contribute to the declining effectiveness of current treatments.

Conclusions:

  • A comprehensive understanding of AMR mechanisms in gram-negative ESKAPE pathogens is essential.
  • This knowledge is vital for designing novel therapeutic strategies.
  • Addressing AMR in these priority pathogens is critical to reduce the global disease burden and mortality.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
52.2K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.7K
Bacterial Transformation01:33

Bacterial Transformation

In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
55.1K
Genomic DNA in Prokaryotes00:46

Genomic DNA in Prokaryotes

The genome of most prokaryotic organisms consists of double-stranded DNA organized into one circular chromosome in a region of cytoplasm called the nucleoid. The chromosome is tightly wound, or supercoiled, for efficient storage. Prokaryotes also contain other circular pieces of DNA called plasmids. These plasmids are smaller than the chromosome and often carry genes that confer adaptive functions, such as antibiotic resistance.
Genomic Diversity in Bacteria
Although bacterial genomes are much...
43.4K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
239